Waters Corporation (WAT)

USD 334.36

(2.81%)

Revenue Summary of Waters Corporation

  • Waters Corporation's latest annual revenue in 2023 was 2.95 Billion USD , down -0.52% from previous year.
  • Waters Corporation's latest quarterly revenue in 2024 Q2 was 708.52 Million USD , up 11.26% from previous quarter.
  • Waters Corporation reported a annual revenue of 2.97 Billion USD in annual revenue 2022, up 6.68% from previous year.
  • Waters Corporation reported a annual revenue of 2.78 Billion USD in annual revenue 2021, up 17.78% from previous year.
  • Waters Corporation reported a quarterly revenue of 708.52 Million USD for 2024 Q2, up 11.26% from previous quarter.
  • Waters Corporation reported a quarterly revenue of 740.3 Million USD for 2024 Q3, up 4.48% from previous quarter.

Annual Revenue Chart of Waters Corporation (2023 - 1995)

Historical Annual Revenue of Waters Corporation (2023 - 1995)

Year Revenue Revenue Growth
2023 2.95 Billion USD -0.52%
2022 2.97 Billion USD 6.68%
2021 2.78 Billion USD 17.78%
2020 2.36 Billion USD -1.71%
2019 2.4 Billion USD -0.55%
2018 2.41 Billion USD 4.8%
2017 2.3 Billion USD 6.54%
2016 2.16 Billion USD 6.12%
2015 2.04 Billion USD 2.66%
2014 1.98 Billion USD 4.47%
2013 1.9 Billion USD 3.29%
2012 1.84 Billion USD -0.41%
2011 1.85 Billion USD 12.65%
2010 1.64 Billion USD 9.65%
2009 1.49 Billion USD -4.85%
2008 1.57 Billion USD 6.93%
2007 1.47 Billion USD 15.06%
2006 1.28 Billion USD 10.53%
2005 1.15 Billion USD 4.86%
2004 1.1 Billion USD 15.27%
2003 958.2 Million USD 7.67%
2002 889.96 Million USD 3.58%
2001 859.2 Million USD 8.07%
2000 795.07 Million USD 12.87%
1999 704.4 Million USD 13.83%
1998 618.8 Million USD 32.93%
1997 465.5 Million USD 19.02%
1996 391.1 Million USD 17.45%
1995 333 Million USD 0.0%

Peer Revenue Comparison of Waters Corporation

Name Revenue Revenue Difference
Agilent Technologies, Inc. 6.83 Billion USD 56.733%
Charles River Laboratories International, Inc. 4.12 Billion USD 28.406%
Quest Diagnostics Incorporated 9.25 Billion USD 68.046%
Danaher Corporation 23.89 Billion USD 87.625%
Enzo Biochem, Inc. 31.9 Million USD -9165.729%
IQVIA Holdings Inc. 14.98 Billion USD 80.27%
Laboratory Corporation of America Holdings 12.16 Billion USD 75.691%
Mettler-Toledo International Inc. 3.78 Billion USD 21.959%
Qiagen N.V. 1.96 Billion USD -50.43%
Revvity, Inc. 2.75 Billion USD -7.484%
Thermo Fisher Scientific Inc. 42.85 Billion USD 93.102%